NCT00519792 - Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Chronic Hepatitis C

Interventions

DRUG

Omega DUROS device

Omega DUROS device 25mcg inserted SC for 48 weeks Omega DUROS device 50mcg inserted SC for 48 weeks

Trial Locations (8)

Weill Cornell Medical College, New York

Duke University Medical Center, Durham

Alamo Medical Research, San Antonio

St. Louis University, St Louis

The Liver Institute at Methodist Dallas, Dallas

Cedars-Sinai Medical Center, Los Angeles

California Pacific Medical Center, San Francisco

Fundacion de Investigacion de Diego, San Juan